(Q55067976)
Statements
Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation. (English)
1 reference
Eleanor Higgins
1 reference
Tariq Al Shehri
1 reference
Maeve A McAleer
1 reference
Niall Conlon
1 reference
Conleth Feighery
1 reference
Desa Lilic
1 reference
1 February 2015
1 reference
135
1 reference
2
1 reference
551-553
1 reference